Free Trial

AMERISAFE, Inc. (NASDAQ:AMSF) Shares Purchased by Barclays PLC

AMERISAFE logo with Finance background

Barclays PLC grew its position in AMERISAFE, Inc. (NASDAQ:AMSF - Free Report) by 365.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 33,219 shares of the insurance provider's stock after acquiring an additional 26,084 shares during the quarter. Barclays PLC owned about 0.17% of AMERISAFE worth $1,605,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the company. Kathleen S. Wright Associates Inc. purchased a new position in AMERISAFE in the 3rd quarter valued at $28,000. Quarry LP raised its position in shares of AMERISAFE by 1,028.4% in the second quarter. Quarry LP now owns 756 shares of the insurance provider's stock valued at $33,000 after buying an additional 689 shares during the last quarter. GAMMA Investing LLC lifted its stake in shares of AMERISAFE by 97.1% in the third quarter. GAMMA Investing LLC now owns 822 shares of the insurance provider's stock worth $40,000 after buying an additional 405 shares in the last quarter. Point72 DIFC Ltd acquired a new position in AMERISAFE during the second quarter worth about $100,000. Finally, BNP Paribas Financial Markets grew its stake in AMERISAFE by 6.9% during the 3rd quarter. BNP Paribas Financial Markets now owns 5,882 shares of the insurance provider's stock valued at $284,000 after acquiring an additional 381 shares in the last quarter. 97.41% of the stock is owned by institutional investors and hedge funds.

AMERISAFE Trading Down 1.3 %

AMSF stock traded down $0.62 during trading on Friday, reaching $48.89. 88,690 shares of the stock were exchanged, compared to its average volume of 76,948. The business has a 50 day moving average price of $54.96 and a 200-day moving average price of $50.72. AMERISAFE, Inc. has a 1 year low of $41.97 and a 1 year high of $60.24. The firm has a market capitalization of $931.35 million, a price-to-earnings ratio of 15.28 and a beta of 0.35.

AMERISAFE (NASDAQ:AMSF - Get Free Report) last released its quarterly earnings results on Wednesday, October 23rd. The insurance provider reported $0.58 EPS for the quarter, beating the consensus estimate of $0.56 by $0.02. The firm had revenue of $78.70 million for the quarter, compared to analyst estimates of $75.38 million. AMERISAFE had a net margin of 19.49% and a return on equity of 16.50%. During the same quarter in the previous year, the company earned $0.61 EPS. On average, research analysts anticipate that AMERISAFE, Inc. will post 2.45 EPS for the current year.

AMERISAFE Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 13th. Investors of record on Friday, December 6th were given a dividend of $3.37 per share. This represents a $13.48 dividend on an annualized basis and a dividend yield of 27.57%. This is an increase from AMERISAFE's previous quarterly dividend of $0.37. The ex-dividend date was Friday, December 6th. AMERISAFE's dividend payout ratio (DPR) is presently 46.25%.

Analyst Ratings Changes

Several brokerages have recently weighed in on AMSF. JMP Securities restated a "market outperform" rating and set a $65.00 target price on shares of AMERISAFE in a report on Tuesday, October 15th. Truist Financial boosted their price objective on AMERISAFE from $48.00 to $54.00 and gave the stock a "hold" rating in a research note on Friday, October 25th.

Check Out Our Latest Stock Report on AMERISAFE

About AMERISAFE

(Free Report)

AMERISAFE, Inc, an insurance holding company, underwrites workers' compensation insurance in the United States. The company provides benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. It sells its products through retail and wholesale brokers and agents; and small and mid-sized employers engaged in hazardous industries, including construction, trucking, logging and lumber, agriculture, manufacturing, telecommunications, and maritime.

See Also

Institutional Ownership by Quarter for AMERISAFE (NASDAQ:AMSF)

Should You Invest $1,000 in AMERISAFE Right Now?

Before you consider AMERISAFE, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMERISAFE wasn't on the list.

While AMERISAFE currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines